Lyophilized peptides remain stable for extended periods as dry powder stored below -15°C, ideally at -50°C or lower, in a tightly sealed container, but degrade steadily once dissolved. This guide explains the chemistry that drives those limits, how to read a peptide sequence before choosing a…
Keep lyophilized peptides as a dry powder in a tightly closed container below -15°C, and prefer -50°C or lower when the peptide will be stored for months or longer. A refrigerator at 4°C is acceptable for short-term storage, and lyophilized material can be shipped at ambient temperature without special handling. Before reconstituting, analyze the sequence and pick a solvent that matches the peptide's charge and hydrophobicity. Once the peptide is dissolved it begins a slow but unavoidable chemical decline, so aliquot and freeze solutions for short periods only, and never rely on solution storage for peptides containing asparagine, glutamine, cysteine, methionine, or tryptophan.
The practical rules below follow the handling documentation published by Bachem, a peptide manufacturer, where this storage and reconstitution guide is the sixth installment in a ten-part series on peptide handling. The recommendations reflect established peptide chemistry and manufacturing experience, but they are not a formal evidence base with published stability curves. This article distinguishes measured fact from working rule of thumb throughout.
Peptides in solution degrade slowly but steadily, regardless of how carefully the solution was prepared. Sterile, oxygen-free conditions remove two drivers of the chemistry but not the chemistry itself. Amide bonds hydrolyze in water, side chains undergo rearrangement and elimination reactions, and reactive residues react with trace oxidants. Lyophilization removes the water that mediates most of this chemistry, and cold storage slows the kinetics of whatever remains. That is the entire logic behind the instruction to store dry and store cold.
In practical terms, lyophilization removes bulk water, but the dry powder is not chemically inert. Degradation continues, far more slowly, which is why the temperature rules apply to the dry powder as well as to solutions. This is the sense in which peptides are stable under appropriate conditions: stable, not permanent.
The degradation rate is sequence dependent. Five residues are the usual shelf-life limiters. Asparagine and glutamine deamidate through cyclic succinimide intermediates, converting to aspartate or isoaspartate and altering the peptide's mass, charge, and biological activity. Methionine oxidizes to methionine sulfoxide, and tryptophan is sensitive to oxidation by dissolved oxygen and trace oxidants. Cysteine is the most demanding of the five because its thiol oxidizes rapidly to disulfides at pH above 7. A peptide containing any of these residues has a limited shelf life, and a peptide containing several carries the combined vulnerabilities of all of them.
The shelf-life limiters, the chemistry behind them, and the protective measures map onto each other.
| Residue | Main degradation pathway | Protective measure |
|---|---|---|
| Asparagine Asn | Deamidation via succinimide intermediate | Dry, cold storage; avoid solution storage |
| Glutamine Gln | Deamidation via succinimide intermediate | Dry, cold storage; avoid solution storage |
| Methionine Met | Oxidation to sulfoxide | Oxygen-free water or buffers; reducing agents |
| Tryptophan Trp | Oxidation by dissolved oxygen and oxidants | Oxygen-free water or buffers |
| Cysteine Cys | Thiol oxidation to disulfides, rapid above pH 7 | Degassed acidic buffers; DTT |
Hygroscopicity is the second threat to a stored lyophilizate. Lyophilized cakes are porous solids with a high surface area, and they take up atmospheric water rapidly once a container is opened. Absorbed moisture lowers the peptide content by simple weight gain, and more importantly it creates local aqueous microenvironments in which degradation resumes. This is why the container must come to ambient temperature in a desiccator before opening and why the powder should be weighed quickly.
The manufacturer's storage specification is simple: keep lyophilized powder in a tightly closed container below -15°C, with -50°C or lower preferred for long-term storage. A standard -20°C laboratory freezer meets the minimum, and an ultracold freezer approaches the preferred condition. The colder the storage, the slower every degradation reaction, which is the practical point of the temperature limit rather than any specific phase change or transition in the material.
Short-term storage is more forgiving. A refrigerator at 4°C is acceptable for peptides that will be used within days or weeks, and lyophilized peptides can be shipped at ambient temperature without damage. The container still needs to be tightly closed in both cases. Most catalogue and custom peptides arrive as lyophilized powders, and the storage conditions are noted on the label; following the label is the correct default.
Container handling matters as much as temperature. Because lyophilized peptides are hygroscopic, a container that has been in the cold should warm to ambient temperature inside a desiccator before it is opened; otherwise moisture condenses on the cold powder. When weighing out material, take the needed amount quickly and reseal the container immediately. For larger quantities, wear a dust respirator, since fine peptide powder can become airborne during weighing.
The most common stability error is storing a peptide as a solution. Manufacturer guidance is explicit: even frozen solutions may be kept only for a few weeks. Long-term storage in solution is not recommended at all, and the restriction is stricter for peptides containing asparagine, glutamine, cysteine, methionine, or tryptophan, the same residues that limit dry-state shelf life. The chemistry explains the rule: dissolving the peptide restores the aqueous medium for hydrolysis, deamidation, and oxidation that lyophilization had removed.
When solution storage is unavoidable, aliquot and freeze below -15°C. Aliquoting is the point of the exercise: it converts one large volume into many small ones so that each thaw exposes only what will be used immediately. The rest remains frozen. This matters because repeated freeze-thaw cycles are themselves damaging to peptide structure and activity, and aliquoting is the standard way to prevent them.
Freezing slows the chemistry but does not stop it. During freezing, solutes concentrate in the remaining liquid, which can locally increase the concentration of reactive species, and pH can shift as components crystallize. These effects are additional reasons that frozen solutions are a short-term expedient, not a storage strategy.
No standard reconstitution protocol exists, because peptide properties vary tremendously. Two peptides of similar length can have opposite solubility behavior based solely on side-chain composition. The first step in any reconstitution is therefore sequence analysis, not trial and error with a favorite solvent.
The 20 proteinogenic amino acids fall into predictive categories. Acidic side chains, aspartate and glutamate, and basic side chains, lysine, arginine, and histidine, are charged at physiological pH. Polar uncharged residues such as serine, threonine, asparagine, glutamine, and tyrosine hydrogen bond with water. Hydrophobic residues such as leucine, isoleucine, valine, phenylalanine, tryptophan, methionine, and alanine resist aqueous solvation. Proline is a special case: dispersed proline residues disrupt secondary structure, and the resulting conformational disorder usually improves solubility.
The terminal amino and carboxyl groups also matter, because they contribute charge at most pH values. The balance of acidic, basic, and neutral residues, including those two termini, determines the peptide's net charge and therefore its first-choice solvent. Solubility depends mainly on polarity and amino acid composition, so the count of charged residues is the single most useful number to calculate before opening the vial.
A working count takes a few minutes. Tally acidic side chains Asp, Glu and the free C-terminus as negative charges, basic side chains Lys, Arg, His and the free N-terminus as positive charges, and read the balance. The dominant sign points to the first solvent: net positive favors acidic conditions, net negative favors basic conditions, and a balanced or hydrophobic sequence points toward organic solvents or neutral buffer at low concentration.
Basic peptides, rich in lysine or arginine, dissolve most readily in a small amount of acidic solvent. Acetic acid or trifluoroacetic acid protonates the basic side chains, increasing their positive charge and therefore their water solubility. The peptide is dissolved in that small volume first, then diluted to the working concentration with water or buffer. The approach is general: start with the minimum volume of the solvent in which the peptide is most soluble, then adjust the medium.
Acidic peptides, rich in aspartate or glutamate, follow the mirror-image logic. A small amount of basic solvent, for example 0.1% aqueous ammonia, deprotonates the acidic side chains, increasing their negative charge and solubility. The stock is then diluted with water. Neutral phosphate-buffered saline at pH 7.0 to 7.4 often works for both classes when a concentration of 1 mg/mL or less is sufficient. That concentration cap is important, because at higher concentrations the same peptide may precipitate. Peptides delivered as trifluoroacetate salts containing a relatively large proportion of arginine and lysine tend to be soluble at neutral pH, so for those sequences PBS is a reasonable first attempt.
The two-step procedure exists because solubility in the first solvent is the bottleneck. A peptide that cannot dissolve in a small volume of the chosen solvent will not dissolve when diluted, and the dilution step simply adapts the concentrated stock to the conditions of the assay. The final solvent concentration and pH must be checked against what the downstream application tolerates, especially when the initial solvent is organic or strongly acidic or basic.
| Peptide character | Initial solvent | Dilute with | Notes |
|---|---|---|---|
| Basic, rich in Lys or Arg | Acetic acid or TFA | Water or buffer | Protonation increases positive charge |
| Acidic, rich in Asp or Glu | 0.1% aqueous ammonia | Water | Deprotonation increases negative charge |
| Hydrophobic or polar uncharged | DMSO, DMF, acetic acid, acetonitrile, methanol, propanol, isopropanol | Water or buffer | High organic solvent is incompatible with cells |
| Aggregation-prone | Urea or guanidinium hydrochloride | Buffer | Denaturants interfere with biological systems |
Peptides with many hydrophobic or polar uncharged residues resist direct dissolution in aqueous buffers. The standard approach is to dissolve them first in a small volume of organic solvent and then dilute with water or buffer. The useful organic solvents are DMSO, DMF, acetic acid, acetonitrile, methanol, propanol, and isopropanol. The high surface tension and hydrogen bonding of water cannot solvate extended hydrophobic stretches, whereas organic solvents engage them more easily.
The caveat is compatibility. High concentrations of organic solvents are incompatible with biological systems, including cultured cells and most enzyme assays. The initial organic stock must therefore be diluted far enough that the final solvent concentration falls below what the assay tolerates. For strongly hydrophobic peptides this can become almost insurmountable in practice; some sequences never reach usable concentrations in aqueous systems, and the researcher must design the assay around that limitation.
Aggregation-prone peptides present a related problem: the peptide dissolves, then assembles into noncovalent structures that come out of solution. Denaturing agents such as urea or guanidinium hydrochloride disrupt the hydrogen bonding and hydrophobic interactions that drive aggregation and can hold the peptide in solution. Their use is limited because these additives interfere with most biological systems, so they are practical only for applications that tolerate them, or when the denaturant can be removed after dissolution.
For peptides containing tryptophan, methionine, or cysteine, reconstitution is a chemical event, not just a physical one. These residues are oxidation targets, and the water or buffer used to dissolve them should be oxygen-free. Degassing, by sparging with an inert gas or by brief vacuum treatment, removes dissolved oxygen before the peptide is added. Reducing agents such as DTT can protect thiols, with the usual caveat that the reducing agent must be compatible with the downstream application.
Free-cysteine peptides deserve the most care because the oxidation is fast. Cysteine thiols are oxidized to disulfides rapidly at pH above 7, so a peptide with a free thiol should be dissolved in a carefully degassed acidic buffer that keeps the thiol protonated. Dissolving in standard neutral buffer, or raising the pH before the peptide is in solution, risks converting the free thiol to a disulfide before the experiment begins. The reaction is rapid, which is why the pH of the dissolution medium is specified rather than left to habit.
Dissolution is not instant. Reconstitution may take up to several hours, especially for larger particles and hydrophobic sequences. Sonication in a water bath for several minutes accelerates dissolution by breaking up larger particles in the liquid, but excessive warming should be avoided: heat accelerates the same degradation reactions the storage rules are designed to prevent. If the peptide does not dissolve within a reasonable time, the fix is to revisit the solvent choice, not to push the suspension harder.
The complete workflow runs from container to assay. First, warm the sealed container to ambient temperature in a desiccator. Second, weigh the needed powder quickly and reseal the container. Third, analyze the sequence and select the initial solvent. Fourth, add a small volume of that solvent and mix gently. Fifth, sonicate briefly in a water bath if dissolution is slow, watching the temperature. Sixth, dilute to the target concentration with water or buffer. Finally, if the solution must be stored, aliquot it, freeze it below -15°C, and use it within a few weeks.
| Do | Don't |
|---|---|
| Equilibrate sealed containers in a desiccator before opening | Open cold containers into humid air |
| Weigh powder quickly and reseal tightly | Leave containers open during weighing |
| Choose the first solvent from sequence charge | Default to PBS for every peptide |
| Degas water or buffer for Cys, Met, or Trp peptides | Dissolve free-cysteine peptides above pH 7 |
| Sonicate briefly in a water bath if dissolution is slow | Heat solutions to speed up dissolution |
| Aliquot and freeze below -15°C for short-term solution storage | Store peptides in solution long term |
The storage and reconstitution rules in this guide are consistent with the documented chemistry of peptide degradation, but the quantitative evidence base is thin. The manufacturer guidance specifies temperature thresholds, moisture precautions, and solvent classes without publishing stability half-lives for representative sequences at each temperature. Statements such as "limited shelf life" for asparagine, glutamine, cysteine, methionine, and tryptophan are qualitative. How much longer a given peptide survives at -50°C than at -20°C is not established, and neither is the rate at which a hygroscopic lyophilizate picks up water at a given humidity.
What is well established is the underlying chemistry. Deamidation of asparagine and glutamine, oxidation of methionine, tryptophan, and cysteine, and hydrolysis of amide bonds in aqueous solution are documented reactions, and the storage rules slow each of them. What remains unresolved is sequence-specific prediction. No substitute exists for testing a particular peptide's solubility and stability under the conditions of the planned experiment, and the manufacturer's own guidance concedes that no standard protocol can be provided because peptide properties vary too widely.
The practical takeaway is deliberately conservative. Treat lyophilized powder as the stable form: store it dry, sealed, and below -15°C, with -50°C or lower for anything long term. Reconstitute deliberately from sequence analysis, protect oxidation-sensitive residues from oxygen and high pH, and regard any solution, frozen or not, as a short-lived intermediate rather than a storage form. These habits will not solve every solubility problem, but they will prevent the failures that come from storage itself.
Related reading: Peptide QC After Synthesis: Identity, Purity, and Net Peptide Content, Peptide Purification After Synthesis: From RP-HPLC to MCSGP, Peptides and Amino Acids: Structure, Classification, and Notation, Peptide Modification Overview: Types, Chemistry, and Applications.